Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) fell $1.20 (57%) to $0.90 on Friday after top-line data from
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury